Contact Us
Cold And Flu Drugs Global Market Report 2025
Global Cold And Flu Drugs Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : May 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Cold And Flu Drugs Global Market Report 2025

By Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, Other Types), By Dosage Form (Tablets, Capsules, Syrups, Lozenges, Other Dosage Forms), By Indication (Congenital Pituitary Dwarfism, Acquired Pituitary Dwarfism, Genetic Syndromes, Other Hormonal Disorders), By Age Group (Pediatric Patients, Adolescent Patients, Adult Patients, Geriatric Patients), By End-User (Hospitals, Specialized Clinics, Homecare Settings, Pharmaceuticals And Research Institutions) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Cold And Flu Drugs Market Overview

• Cold And Flu Drugs market size has reached to $17.35 billion in 2024

• Expected to grow to $27.88 billion in 2029 at a compound annual growth rate (CAGR) of 10%

• Growth Driver: Rising Incidence Of Viral Infections Driving The Growth Of The Market Due To Factors Like Travel, Urbanization, And Emerging Virus Strains

• Market Trend: Focus On Clean Over-The-Counter (OTC) Medicines Driving Innovation In The Market With Safer, Natural Alternatives For Children

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cold And Flu Drugs Market?

Cold and flu drugs are pharmaceutical medications that alleviate symptoms associated with the common cold and influenza (flu). These medications help relieve fever, cough, congestion, sore throat, body aches, and other related symptoms, improving overall comfort and recovery.

The main types of cold and flu drugs include antihistamines, expectorants, bronchodilators, decongestants, and other types. Antihistamines are drugs that block histamine receptors to relieve allergy and cold symptoms such as sneezing, itching, and nasal congestion. These drugs are available in various dosage forms, including tablets, capsules, syrups, lozenges, and other forms. They are used for various indications, including congenital pituitary dwarfism, acquired pituitary dwarfism, genetic syndromes, and other hormonal disorders. These drugs are administered to different age groups, including pediatric, adolescent, adult, and geriatric patients. They are used by various end users, including hospitals, specialized clinics, homecare settings, pharmaceutical companies, and research institutions.

Cold And Flu Drugs Market Size and growth rate 2025 to 2029: Graph

What Is The Cold And Flu Drugs Market Size 2025 And Growth Rate?

The cold and flu drugs market size has grown rapidly in recent years. It will grow from $17.35 billion in 2024 to $19.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising aging population, rising popularity of over-the-counter (OTC) medications, growing urbanization, rising demand for herbal and natural remedies, and increasing healthcare expenditure.

What Is The Cold And Flu Drugs Market Growth Forecast?

The cold and flu drugs market size is expected to see rapid growth in the next few years. It will grow to $27.88 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing prevalence of seasonal influenza, rise in air pollution contributing to respiratory infections, rise in cases of antibiotic resistance, rising popularity of immunity-boosting supplements, and increasing awareness about self-medication. Major trends in the forecast period include personalized medicine, development of combination products and natural remedies, advancements in nasal sprays and inhalers, strategic collaborations, and development of fast-acting formulations.

The forecast of 10.0% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. retail pharmacies by increasing the cost of OTC cold and flu medications sourced from India and China, thereby reducing seasonal illness treatment accessibility and elevating consumer healthcare expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Cold And Flu Drugs Market Segmented?

1) By Type: Antihistamines, Expectorants, Bronchodilators, Decongestants, Other Types

2) By Dosage Form: Tablets, Capsules, Syrups, Lozenges, Other Dosage Forms

3) By Indication: Congenital Pituitary Dwarfism, Acquired Pituitary Dwarfism, Genetic Syndromes, Other Hormonal Disorders

4) By Age Group: Pediatric Patients, Adolescent Patients, Adult Patients, Geriatric Patients

5) By End-User: Hospitals, Specialized Clinics, Homecare Settings, Pharmaceuticals And Research Institutions

Subsegments:

1) By Type: First-Generation Antihistamines, Second-Generation Antihistamines, Combination Antihistamines

2) By Type: Guaifenesin-Based Expectorants, Herbal Expectorants, Combination Expectorants

3) By Type: Beta-Agonists, Anticholinergics, Combination Bronchodilators

4) By Type: Oral Decongestants, Nasal Spray Decongestants, Combination Decongestants

5) By Type: Pain Relievers, Cough Suppressants, Antipyretics, Nasal Sprays, Immune Boosters

What Is Driving The Cold And Flu Drugs Market? Rising Incidence Of Viral Infections Driving The Growth Of The Market Due To Factors Like Travel, Urbanization, And Emerging Virus Strains

The increasing incidence of viral infections is expected to propel the growth of the cold and flu drugs market going forward. A viral infection is an illness caused by viruses that invade and multiply within host cells, leading to various symptoms. The increasing incidence of viral infections is due to rising travel, leading to the spread of viruses across regions and countries, allowing them to reach new populations and cause outbreaks. Cold and flu drugs control viral infections by reducing symptoms such as fever, congestion, and pain, providing relief while the immune system combats the virus. For instance, in January 2025, according to the Pan American Health Organization, a US-based specialized agency in charge of international health cooperation in the Americas, influenza positivity was 22.05% globally in early January 2025, showing a 20% seasonal increase. Therefore, the increasing incidence of viral infections drives the growth of the cold and flu drugs industry.

Who Are The Major Players In The Global Cold And Flu Drugs Market?

Major companies operating in the cold and flu drugs market are Johnson & Johnson, Roche Holding AG, Bayer AG, Sanofi S.A., Viatris Inc., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Pyxus International Inc., Glenmark Pharmaceuticals Ltd., The Kroger Co., Saphnix Life Sciences, Arlak Biotech Pvt Ltd, AdvaCare Pharma, Sterling Pharmaceuticals, Biophar Lifesciences Pvt Ltd, Nutra Respiro

What Are The Key Trends Of The Global Cold And Flu Drugs Market? Focus On Clean Over-The-Counter (OTC) Medicines Driving Innovation In The Market With Safer, Natural Alternatives For Children

Major companies operating in the cold and flu drugs market are focusing on developing innovative products such as clean over-the-counter (OTC) medicines to provide safer, natural alternatives for children without artificial additives. Over-the-counter (OTC) medicines are drugs that can be purchased without a prescription, typically used to treat everyday ailments such as headaches, colds, and minor pain. For instance, in September 2023, Genexa Inc., a US-based clean medicine company, introduced clean over-the-counter (OTC) children's medicines, such as the Kids' Multi-Symptom Cold & Flu and Kids' Daytime + Nighttime Cough Relief Value Pack. These products utilize effective active ingredients without artificial dyes, sweeteners, or preservatives, offering a safer, more natural alternative for children's cold and flu treatments while enhancing symptom relief for conditions like fever, sore throat, and congestion.

Need data on a specific region in this market?

What Are Latest Mergers And Acquisitions In The Cold And Flu Drugs Market? Vir Biotechnology Partners With Glaxosmithkline To Advance Respiratory Therapies

In February 2023, Vir Biotechnology Inc., a US-based biotechnology company, partnered with GlaxoSmithKline to advance new therapies for influenza. With this partnership, Vir Biotechnology and GSK aim to ensure ongoing access to sotrovimab for authorized patients while jointly advancing the development of new treatments for influenza and other respiratory diseases, with Vir also independently pursuing next-generation solutions for COVID-19 and potential future coronavirus outbreaks. GlaxoSmithKline is a UK-based biopharma company specializing in over-the-counter (OTC) medications for cold and flu symptoms.

What Is The Regional Outlook For The Global Cold And Flu Drugs Market?

North America was the largest region in the cold and flu drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cold And Flu Drugs Market?

The cold and flu drugs market consist of sales of cough suppressants, nasal sprays, antiviral medications, sore throat sprays, and fever reducers. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Cold And Flu Drugs Industry?

The cold and flu drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cold and flu drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Cold And Flu Drugs Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $19.01 billion
Revenue Forecast In 2034 $27.88 billion
Growth Rate CAGR of 10% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The cold and flu drugs market covered in this report is segmented –
1) By Type: Antihistamines, Expectorants, Bronchodilators, Decongestants, Other Types
2) By Dosage Form: Tablets, Capsules, Syrups, Lozenges, Other Dosage Forms
3) By Indication: Congenital Pituitary Dwarfism, Acquired Pituitary Dwarfism, Genetic Syndromes, Other Hormonal Disorders
4) By Age Group: Pediatric Patients, Adolescent Patients, Adult Patients, Geriatric Patients
5) By End-User: Hospitals, Specialized Clinics, Homecare Settings, Pharmaceuticals And Research Institutions Subsegments:
1) By Type: First-Generation Antihistamines, Second-Generation Antihistamines, Combination Antihistamines
2) By Type: Guaifenesin-Based Expectorants, Herbal Expectorants, Combination Expectorants
3) By Type: Beta-Agonists, Anticholinergics, Combination Bronchodilators
4) By Type: Oral Decongestants, Nasal Spray Decongestants, Combination Decongestants
5) By Type: Pain Relievers, Cough Suppressants, Antipyretics, Nasal Sprays, Immune Boosters
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Request for Sample
Customization ScopeExplore Purchase Options
Pricing And Purchase Options

Table Of Contents

1. Executive Summary

2. Cold And Flu Drugs Market Characteristics

3. Cold And Flu Drugs Market Trends And Strategies

4. Cold And Flu Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Cold And Flu Drugs Growth Analysis And Strategic Analysis Framework

5.1. Global Cold And Flu Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Cold And Flu Drugs Market Growth Rate Analysis

5.4. Global Cold And Flu Drugs Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Cold And Flu Drugs Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Cold And Flu Drugs Total Addressable Market (TAM)

6. Cold And Flu Drugs Market Segmentation

6.1. Global Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antihistamines

Expectorants

Bronchodilators

Decongestants

Other Types

6.2. Global Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Tablets

Capsules

Syrups

Lozenges

Other Dosage Forms

6.3. Global Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Congenital Pituitary Dwarfism

Acquired Pituitary Dwarfism

Genetic Syndromes

Other Hormonal Disorders

6.4. Global Cold And Flu Drugs Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pediatric Patients

Adolescent Patients

Adult Patients

Geriatric Patients

6.5. Global Cold And Flu Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialized Clinics

Homecare Settings

Pharmaceuticals And Research Institutions

6.6. Global Cold And Flu Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

First-Generation Antihistamines

Second-Generation Antihistamines

Combination Antihistamines

6.7. Global Cold And Flu Drugs Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Guaifenesin-Based Expectorants

Herbal Expectorants

Combination Expectorants

6.8. Global Cold And Flu Drugs Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Beta-Agonists

Anticholinergics

Combination Bronchodilators

6.9. Global Cold And Flu Drugs Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Decongestants

Nasal Spray Decongestants

Combination Decongestants

6.10. Global Cold And Flu Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pain Relievers

Cough Suppressants

Antipyretics

Nasal Sprays

Immune Bosters

7. Cold And Flu Drugs Market Regional And Country Analysis

7.1. Global Cold And Flu Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Cold And Flu Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Cold And Flu Drugs Market

8.1. Asia-Pacific Cold And Flu Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Cold And Flu Drugs Market

9.1. China Cold And Flu Drugs Market Overview

9.2. China Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Cold And Flu Drugs Market

10.1. India Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Cold And Flu Drugs Market

11.1. Japan Cold And Flu Drugs Market Overview

11.2. Japan Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Cold And Flu Drugs Market

12.1. Australia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Cold And Flu Drugs Market

13.1. Indonesia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Cold And Flu Drugs Market

14.1. South Korea Cold And Flu Drugs Market Overview

14.2. South Korea Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Cold And Flu Drugs Market

15.1. Western Europe Cold And Flu Drugs Market Overview

15.2. Western Europe Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Cold And Flu Drugs Market

16.1. UK Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Cold And Flu Drugs Market

17.1. Germany Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Cold And Flu Drugs Market

18.1. France Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Cold And Flu Drugs Market

19.1. Italy Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Cold And Flu Drugs Market

20.1. Spain Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Cold And Flu Drugs Market

21.1. Eastern Europe Cold And Flu Drugs Market Overview

21.2. Eastern Europe Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Cold And Flu Drugs Market

22.1. Russia Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Cold And Flu Drugs Market

23.1. North America Cold And Flu Drugs Market Overview

23.2. North America Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Cold And Flu Drugs Market

24.1. USA Cold And Flu Drugs Market Overview

24.2. USA Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Cold And Flu Drugs Market

25.1. Canada Cold And Flu Drugs Market Overview

25.2. Canada Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Cold And Flu Drugs Market

26.1. South America Cold And Flu Drugs Market Overview

26.2. South America Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Cold And Flu Drugs Market

27.1. Brazil Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Cold And Flu Drugs Market

28.1. Middle East Cold And Flu Drugs Market Overview

28.2. Middle East Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Cold And Flu Drugs Market

29.1. Africa Cold And Flu Drugs Market Overview

29.2. Africa Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Cold And Flu Drugs Market Competitive Landscape And Company Profiles

30.1. Cold And Flu Drugs Market Competitive Landscape

30.2. Cold And Flu Drugs Market Company Profiles

30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Cold And Flu Drugs Market Other Major And Innovative Companies

31.1. Reckitt Benckiser Group plc

31.2. Sun Pharmaceutical Industries Ltd.

31.3. Perrigo Company plc

31.4. Dr. Reddy’s Laboratories Ltd.

31.5. Hikma Pharmaceuticals plc

31.6. Lupin Limited

31.7. Pyxus International Inc.

31.8. Glenmark Pharmaceuticals Ltd.

31.9. The Kroger Co.

31.10. Saphnix Life Sciences

31.11. Arlak Biotech Pvt Ltd

31.12. AdvaCare Pharma

31.13. Sterling Pharmaceuticals

31.14. Biophar Lifesciences Pvt Ltd

31.15. Nutra Respiro

32. Global Cold And Flu Drugs Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Cold And Flu Drugs Market

34. Recent Developments In The Cold And Flu Drugs Market

35. Cold And Flu Drugs Market High Potential Countries, Segments and Strategies

35.1 Cold And Flu Drugs Market In 2029 - Countries Offering Most New Opportunities

35.2 Cold And Flu Drugs Market In 2029 - Segments Offering Most New Opportunities

35.3 Cold And Flu Drugs Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Cold And Flu Drugs Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Cold And Flu Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Cold And Flu Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Cold And Flu Drugs Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Cold And Flu Drugs Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Cold And Flu Drugs Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Cold And Flu Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Global Cold And Flu Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Global Cold And Flu Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: Asia-Pacific, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: Asia-Pacific, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: China, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: China, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: India, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: India, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Japan, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Japan, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Australia, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Australia, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Indonesia, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Indonesia, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: South Korea, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: South Korea, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Western Europe, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Western Europe, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: UK, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: UK, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Germany, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Germany, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: France, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: France, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Italy, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Italy, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Spain, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Spain, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Eastern Europe, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Eastern Europe, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: Russia, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: Russia, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: North America, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: North America, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: USA, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: USA, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Canada, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Canada, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: South America, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: South America, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Brazil, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Brazil, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Middle East, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Middle East, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Africa, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 80: Africa, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 81: Johnson & Johnson Financial Performance
  • Table 82: Roche Holding AG Financial Performance
  • Table 83: Bayer AG Financial Performance
  • Table 84: Sanofi S.A. Financial Performance
  • Table 85: Viatris Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Cold And Flu Drugs Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Cold And Flu Drugs Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Cold And Flu Drugs Market, Sub-Segmentation Of Antihistamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Cold And Flu Drugs Market, Sub-Segmentation Of Expectorants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Cold And Flu Drugs Market, Sub-Segmentation Of Bronchodilators, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Cold And Flu Drugs Market, Sub-Segmentation Of Decongestants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Cold And Flu Drugs Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Global Cold And Flu Drugs Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Global Cold And Flu Drugs Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: Asia-Pacific, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: Asia-Pacific, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: China, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: China, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: India, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: India, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Japan, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Japan, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Australia, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Australia, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Indonesia, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Indonesia, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: South Korea, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: South Korea, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Western Europe, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Western Europe, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: UK, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: UK, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Germany, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Germany, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: France, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: France, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Italy, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Italy, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Spain, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Spain, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Eastern Europe, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Eastern Europe, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: Russia, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: Russia, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: North America, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: North America, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: USA, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: USA, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Canada, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Canada, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: South America, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: South America, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Brazil, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Brazil, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Middle East, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Middle East, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Cold And Flu Drugs Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Africa, Cold And Flu Drugs Market, Segmentation By Dosage Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 80: Africa, Cold And Flu Drugs Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 81: Johnson & Johnson Financial Performance
  • Figure 82: Roche Holding AG Financial Performance
  • Figure 83: Bayer AG Financial Performance
  • Figure 84: Sanofi S.A. Financial Performance
  • Figure 85: Viatris Inc. Financial Performance

Frequently Asked Questions

Cold and flu drugs are pharmaceutical medications that alleviate symptoms associated with the common cold and influenza (flu). These medications help relieve fever, cough, congestion, sore throat, body aches, and other related symptoms, improving overall comfort and recovery. For further insights on this market, request a sample here

The market major growth driver - Rising Incidence Of Viral Infections Driving The Growth Of The Market Due To Factors Like Travel, Urbanization, And Emerging Virus Strains. For further insights on this market, request a sample here

The cold and flu drugs market size has grown strongly in recent years. It will grow from $17.35 billion in 2024 to $19.01 billion in 2025 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising aging population, rising popularity of over-the-counter (OTC) medications, growing urbanization, rising demand for herbal and natural remedies, and increasing healthcare expenditure. The cold and flu drugs market size is expected to see rapid growth in the next few years. It will grow to " $27.88 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to increasing prevalence of seasonal influenza, rise in air pollution contributing to respiratory infections, rise in cases of antibiotic resistance, rising popularity of immunity-boosting supplements, and increasing awareness about self-medication. Major trends in the forecast period include personalized medicine, development of combination products and natural remedies, advancements in nasal sprays and inhalers, strategic collaborations, and development of fast-acting formulations. For further insights on this market, request a sample here

The cold and flu drugs market covered in this report is segmented –
1) By Type: Antihistamines, Expectorants, Bronchodilators, Decongestants, Other Types
2) By Dosage Form: Tablets, Capsules, Syrups, Lozenges, Other Dosage Forms
3) By Indication: Congenital Pituitary Dwarfism, Acquired Pituitary Dwarfism, Genetic Syndromes, Other Hormonal Disorders
4) By Age Group: Pediatric Patients, Adolescent Patients, Adult Patients, Geriatric Patients
5) By End-User: Hospitals, Specialized Clinics, Homecare Settings, Pharmaceuticals And Research Institutions Subsegments:
1) By Type: First-Generation Antihistamines, Second-Generation Antihistamines, Combination Antihistamines
2) By Type: Guaifenesin-Based Expectorants, Herbal Expectorants, Combination Expectorants
3) By Type: Beta-Agonists, Anticholinergics, Combination Bronchodilators
4) By Type: Oral Decongestants, Nasal Spray Decongestants, Combination Decongestants
5) By Type: Pain Relievers, Cough Suppressants, Antipyretics, Nasal Sprays, Immune Boosters For further insights on this market,
request a sample here

North America was the largest region in the cold and flu drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cold and flu drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the cold and flu drugs market are Johnson & Johnson, Roche Holding AG, Bayer AG, Sanofi S.A., Viatris Inc., Reckitt Benckiser Group plc, Sun Pharmaceutical Industries Ltd., Perrigo Company plc, Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals plc, Lupin Limited, Pyxus International Inc., Glenmark Pharmaceuticals Ltd., The Kroger Co., Saphnix Life Sciences, Arlak Biotech Pvt Ltd, AdvaCare Pharma, Sterling Pharmaceuticals, Biophar Lifesciences Pvt Ltd, Nutra Respiro . For further insights on this market, request a sample here.

Major trends in this market include Focus On Clean Over-The-Counter (OTC) Medicines Driving Innovation In The Market With Safer, Natural Alternatives For Children. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top
\
Back to top